1,472 reports of this reaction
1.9% of all ESTRADIOL GEL 0.1% reports
#10 most reported adverse reaction
ARTHRALGIA is the #10 most commonly reported adverse reaction for ESTRADIOL GEL 0.1%, manufactured by ANI Pharmaceuticals, Inc.. There are 1,472 FDA adverse event reports linking ESTRADIOL GEL 0.1% to ARTHRALGIA. This represents approximately 1.9% of all 79,046 adverse event reports for this drug.
Patients taking ESTRADIOL GEL 0.1% who experience arthralgia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ARTHRALGIA is a less commonly reported adverse event for ESTRADIOL GEL 0.1%, but still significant enough to appear in the safety profile.
In addition to arthralgia, the following adverse reactions have been reported for ESTRADIOL GEL 0.1%:
The following drugs have also been linked to arthralgia in FDA adverse event reports:
ARTHRALGIA has been reported as an adverse event in 1,472 FDA reports for ESTRADIOL GEL 0.1%. This does not prove causation, but indicates an association observed in post-market surveillance data.
ARTHRALGIA accounts for approximately 1.9% of all adverse event reports for ESTRADIOL GEL 0.1%, making it a notable side effect.
If you experience arthralgia while taking ESTRADIOL GEL 0.1%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.